OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Overview Fund Activity
Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings

23 hedge funds and large institutions have $10.3M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
7
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BC
Broadfin Capital
New York
$1.12M
2
FM
Fondren Management
Texas
$1.04M
3
GIP
Granite Investment Partners
California
$356K
4
SIM
Spark Investment Management
New York
$198K
5
Vanguard Group
Vanguard Group
Pennsylvania
$1.64M

Top Sellers

1
SCM
Stonepine Capital Management
Oregon
$3.87M
2
EIM
Essex Investment Management
Massachusetts
$302K
3
UOC
UBS O'Connor
Illinois
$0
4
BCM
Brasada Capital Management
Texas
$0
5
GPCM
Granite Point Capital Management
Massachusetts
$761K
Name Holding Trade Value Shares
Change 		Shares
Change %
EP
26
Eversept Partners
New York
– -$201K -13,901 Closed
RA
27
Royce & Associates
New York
– -$9K -623 Closed
GI
28
Gradient Investments
Minnesota
– -$5K -350 Closed
1
2